Skip to main content
Landing Pages / Faculty Profile
Photo of  Amoah Yeboah-Korang, MD, MPH

Amoah Yeboah-Korang, MD, MPH

Assistant Professor of Clinical

Internal Medicine | College of Medicine

Education/Credentials
  • BS, MS: University of Massachusetts
  • MD, MPH: University of Connecticut School of Medicine
  • Residency: Rush University Medical Center
  • Fellowship: NorthShore University Health System
  • Fellowship: University of Michigan Health System
Board Certifications & Licenses

American Board of Internal Medicine (Gastroenterology) (Certification Date: 20181017)
American Board of Internal Medicine (Certification Date: 20150811)
American Board of Internal Medicine (Transplant Medicine) (Certification Date: 20201015)

Clinical Interest

Gastroenterology
Transplant Hepatology
Acute Liver Failure
Alcoholic Liver Disease
Autoimmune Hepatitis
Fatty Liver

Specialties

Gastroenterology
Internal Medicine
Transplant Hepatology

Contact Information

Peer Reviewed Publications

Fang, Jiayun M; Lamps, Laura; Yeboah-Korang, Amoah; Cheng, Jerome; Westerhoff, Maria 2021. De Novo Inflammatory Bowel Disease Rarely Occurs During Posttransplant Immunosuppression. American journal of clinical pathology, ,

Yeboah-Korang, Amoah; Louissaint, Jeremy; Tsung, Irene; Prabhu, Sharmila; Fontana, Robert J 2020. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record. Drug safety, 43 4, 371-377

Tsung, Irene; Dolan, Russell; Lao, Christopher D; Fecher, Leslie; Riggenbach, Kane; Yeboah-Korang, Amoah; Fontana, Robert J 2019. Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy. Alimentary pharmacology & therapeutics, 50 7, 800-808

Yeboah-Korang, Amoah; Beig, Mohammad I; Khan, Mohammad Q; Goldstein, Jay L; Macapinlac, Don M; Maurer, Darryck; Sonnenberg, Amnon; Fimmel, Claus J 2018. Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert. Journal of translational internal medicine, 6 2, 82-89

Yeboah-Korang, Amoah; Gentile, Nicole M; Fimmel, Claus J 2018. PRO: Patients With Hepatitis C Virus With Pretreatment Metavir Stage 3 Fibrosis Do Not Require Hepatocellular Carcinoma Surveillance After Sustained Virological Response. Clinical liver disease, 12 5, 133-136

Yeboah-Korang, Amoah; Kleppinger, Alison; Fortinsky, Richard H 2011. Racial and ethnic group variations in service use in a national sample of Medicare home health care patients with type 2 diabetes mellitus. Journal of the American Geriatrics Society, 59 6, 1123-9